Nephron recalls 50 mL hydromorphone injections with potential sterility issues. Affected lots may cause infections if used.
Lack of Assurance of Sterility
Nephron is recalling hydromorphone injections that may not be sterile. Using these could lead to infections, especially in medical settings.
The injections may not be sterile, which could lead to infections if used improperly. This is a risk in medical settings where sterility is critical.
Healthcare providers and patients using the recalled hydromorphone injections for pain management. Those with the specific lot number are most at risk.
Check for the lot number HN2005A on the syringe carton. The product was sold with NDC 69374-559-50 and expires 9/17/2022.
Look for lot number HN2005A on the syringe carton to confirm if it's affected.
The recall indicates a lack of sterility assurance, so it should not be used until the remedy is confirmed.
Check the lot number on the syringe carton. If it's HN2005A, contact Nephron for guidance.
The recall record does not specify a replacement process.
We’ve drafted a message you can send Nephron to request your refund or repair — edit it as you like.
Subject: Recall D-0957-2022 — Nephron Nephron Hello, I own a Nephron that is covered by recall D-0957-2022 from Nephron. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
